The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Colchicine induces apoptosis in HT-29 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite COL not yet being used clinically for cancer therapy because of its toxicity to normal cells, it is used as a lead compound in generating potent anticancer agents [5,6,7,8,9].”
From Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles (2020) · cites this paper as [6]
In the citing paper
“It was reported that free COL decreased mitochondrial membrane potential in HT-29 colon cells, which led to intrinsic apoptotic cell death [6].”
From Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JNK promotes Bax translocation to mitochondria through phosphorylation of 14‐3‐3 proteins
Tsuruta, F., Sunayama, J., Mori, Y., Hattori, S., Shimizu, S., Tsujimoto, Y., Yoshioka, K., Masuyama, N., & Gotoh, Y. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600194 · Cited by 556
Flagged first, then by citations
Research works printed but not linked: 24
- Giovannucci, 2002, Modifiable risk factors for colon cancer, Gastroenterol Clin North Am, 31, 925, 10.1016/S0889-8553(02)00057-2 · DOI
- Couzin, 2006, Cancer T cells a boon for colon cancer prognosis, Science, 313, 1868, 10.1126/science.313.5795.1868b · DOI
- François, 1991, Cancer of the colon. Etiology, physiopathology, diagnosis, development and prognosis, principles of the surgical treatment, Rev Prat, 41, 1221
- Chiu, 2003, Dietary factors and risk of colon cancer in Shanghai, China, Cancer Epidemiol, Biomarkers Prev, 12, 201
- Barrier, 2006, Stage II colon cancer prognosis prediction by tumor gene expression profiling, J Clin Oncol, 24, 4685, 10.1200/JCO.2005.05.0229 · DOI
- Jee, 2011, Effectiveness of adjuvant chemotherapy with 5-FU/leucovorin and prognosis in stage II colon cancer, J Korean Soc Coloproctol, 27, 322, 10.3393/jksc.2011.27.6.322 · DOI
- Dotan, 2011, Challenges in the management of stage II colon cancer, Semin Oncol, 38, 511, 10.1053/j.seminoncol.2011.05.005 · DOI
- Risinger, 2010, Taccalonolides: Novel micro-tubule stabilizers with clinical potential, Cancer Lett, 291, 14, 10.1016/j.canlet.2009.09.020 · DOI
- Sivakumar, 2013, Colchicine semisynthetics: Chemotherapeutics for cancer?, Curr Med Chem, 20, 892
- Risinger, 2009, Microtubule dynamics as a target in oncology, Cancer Treat Rev, 35, 255, 10.1016/j.ctrv.2008.11.001 · DOI
- Jordan, 2004, Microtubules as a target for anticancer drugs, Nat Rev Cancer, 4, 253, 10.1038/nrc1317 · DOI · Paper page
- Ravelli, 2004, Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain, Nature, 428, 198, 10.1038/nature02393 · DOI
- Bhattacharyya, 2008, Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin, Med Res Rev, 28, 155, 10.1002/med.20097 · DOI · Paper page
- Chopra, 2014, Novel piperazine-based compounds inhibit microtubule dynamics and sensitize colon cancer cells to tumor necrosis factor-induced apoptosis, J Biol Chem, 289, 2978, 10.1074/jbc.M113.499319 · DOI
- Acharya, 2014, Thymoquinone inhibits microtubule polymerization by tubulin binding and causes mitotic arrest following apoptosis in A549 cells, Biochimie, 97, 78, 10.1016/j.biochi.2013.09.025 · DOI
- Rai, 2013, CXI-benzo-84 reversibly binds to tubulin at colchicine site and induces apoptosis in cancer cells, Biochem Pharmacol, 86, 378, 10.1016/j.bcp.2013.05.024 · DOI
- Magalhães, 2013, (4-Methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone inhibits tubulin polymerization, induces G2/M arrest and triggers apoptosis in human leukemia HL-60 cells, Toxicol Appl Pharmacol, 272, 117, 10.1016/j.taap.2013.06.001 · DOI
- Chiang, 2013, A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway, PLoS One, 8, e58953, 10.1371/journal.pone.0058953 · DOI
- Wu, 2012, Antiproliferative and cell apoptosis-inducing activities of compounds from Buddleja davidii in Mgc-803 cells, Cell Div, 7, 20, 10.1186/1747-1028-7-20 · DOI
- Wang, 2001, The expanding role of mitochondria in apoptosis, Genes Dev, 15, 2922
- Zamzami, 1996, Inhibitors of permeability transition interfere with the disruption of the mitochondrial trans-membrane potential during apoptosis, FEBS Lett, 384, 53, 10.1016/0014-5793(96)00280-3 · DOI
- Yan, 2010, Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines, Toxicol In Vitro, 24, 842, 10.1016/j.tiv.2009.12.008 · DOI
- Roux, 2004, ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions, Microbiol Mol Biol Rev, 68, 320, 10.1128/MMBR.68.2.320-344.2004 · DOI
- Pugazhenthi, 2000, Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein, J Biol Chem, 275, 10761, 10.1074/jbc.275.15.10761 · DOI · Paper page
Cited by
Sorted by citations
Dhyani, P., Quispe, C., Sharma, E., Bahukhandi, A., Sati, P., Attri, D. C., Szopa, A., Sharifi-Rad, J., Docea, A. O., Mardare, I., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02624-9 · Cited by 483
AbouAitah, K., Hassan, H. A., Swiderska-Sroda, A., Gohar, L., Shaker, O. G., Wojnarowicz, J., Opalinska, A., Smalc-Koziorowska, J., Gierlotka, S., & Lojkowski, W. (2020) · Cancers · doi:10.3390/cancers12010144 · Cited by 105
Metadata
- Authors
- HUANG, Z., XU, Y., & PENG, W.
- Venue
- Molecular Medicine Reports
- Publisher
- Spandidos Publications
- Published
- 2015-08-12
- Volume
- 12
- Issue
- 4
- Pages
- 5939-5944
- ISSN
- 1791-2997
- 1791-3004
- Cited by
- 51
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
